Maxim Group Maintains a Buy Rating on Sensus Healthcare (SRTS)

Maxim Group analyst Anthony Vendetti maintained a Buy rating on Sensus Healthcare (SRTS – Research Report) yesterday and set a price target of $6.00. The company’s shares closed last Friday at $3.40. More »

The Chief Business Officer of CGI Group is Exercising Options

Yesterday it was reported that the Chief Business Officer of CGI Group (GIB – Research Report), Mark Boyajian, exercised options to sell 12,599 GIB shares for a total transaction value of $1.38M. More »